CathWorks news
CathWorks, an original equipment manufacturer (OEM), and Quest International, a global service support provider to the OEMs, announced today they have signed a post-sales technical service support agreement that Quest International becomes the preferred technical service delivery partner for end-to-end service support of CathWorks’ fast-growing install-base of customers globally. CathWorks plans to leverage Quest’s capabilities to accelerate its commercial operations and expand it
CathWorks announced today that the results of its most recent outcomes study on the CathWorks FFRangio™ system will be presented by Dr. Guy Witberg from Rabin Medical Center, Petah Tikva, Israel on Sunday, April 3 at the annual American College of Cardiology (ACC) conference in Washington, DC.
Dr. Witberg and his co-investigators in Israel and Japan examined the 1-year clinical outcomes of 492 patients whose treatment decision was based solely on the CathWorks FFRangio™ Sy
CathWorks, a global leader of digital health innovation focused on helping patients with cardiovascular disease, announced today that Mike Feher was appointed Chief Financial Officer, effective immediately.
An energetic and results-driven executive, Mr. Feher brings comprehensive strategic and operational finance experience to his role, including expertise in financial planning and analysis, strategy, investor relations, operational execution, and much more. Most recently, he wa
CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the application to provide reimbursement for the CathWorks FFRangio™ System, making it more broadly available for coronary artery disease decision-making in Japan. The CathWorks FFRangio™ System has already received regulatory approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) in December 2019 and is also commercially available in the United States and Europe.
The CathWorks FFRangio System is revolutionizing treatment decisions for coronary artery disease with quick, non-invasive, wire-free 3D FFR guidance.
In this excerpt from his webinar presentation at CVIT Japan 2021, Dr. Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Medical Center, presents a case study that demonstrates the highly accurate multi-vessel FFR insights delivered by the FFRangio System.
The latest CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance that is practical for every case.
In this video highlight from CVIT Japan 2021, Dr. Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Medical Center, gives a “live” view of the software interface and details the essential information depicted on screen, including:
- Accurate multi-vessel FFR
FFRangio is a non-invasive, angiography-based system that provides quick, wire-free, and drug-free assessment of FFR for multiple vessels.
In this video highlight from CVIT Japan 2021, Dr. Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Medical Center, gives an overview of how FFRangio works.
Topics include:
- 3D model reconstruction – including 3D QCA fro
CathWorks , a global leader of digital health innovation focused on helping patients with cardiovascular disease, today announced that Ramin Mousavi has been appointed Chief Executive Officer, effective June 21, 2021. Mr. Mousavi has also been appointed to the company’s Board of Directors. Mr. Mousavi succeeds Jim Corbett, who served as the company’s CEO since October 27, 2017.
A rising star of the medical device industry, Mr. Mousavi has executive leadership and operation
In this virtual webinar presentation from CVIT Japan 2021, Dr. Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Medical Center, shares his experience with the latest FFRangio software and discusses important benefits of FFRangio for routine clinical practice.
At the end of the video, there is a question-and-answer session with renowned cardiologists Dr. Hitoshi Matsuo of Gifu Heart Center and Dr. Hiroyoshi Yokoi of Fukuoka Sanno Hospi
CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW).
The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks FFRangio System transforms routine angiogram images into objective and comprehensive physiology information, including color-coded 3D renderings of blood flow in the heart’s arteries to help physicians